Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1.

MLA

Fagone, P., et al. “Prevention of Clinical and Histological Signs of Proteolipid Protein (PLP)-Induced Experimental Allergic Encephalomyelitis (EAE) in Mice by the Water-Soluble Carbon Monoxide-Releasing Molecule (CORM)-A1.” Clinical and Experimental Immunology, vol. 163, no. 3, Mar. 2011, pp. 368–74. EBSCOhost, https://doi.org/10.1111/j.1365-2249.2010.04303.x.

APA

Fagone, P., Mangano, K., Quattrocchi, C., Motterlini, R., Di Marco, R., Magro, G., Penacho, N., Romao, C. C., & Nicoletti, F. (2011). Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1. Clinical and Experimental Immunology, 163(3), 368–374. https://doi.org/10.1111/j.1365-2249.2010.04303.x

Chicago

Fagone, P, K Mangano, C Quattrocchi, R Motterlini, R Di Marco, G Magro, N Penacho, C C Romao, and F Nicoletti. 2011. “Prevention of Clinical and Histological Signs of Proteolipid Protein (PLP)-Induced Experimental Allergic Encephalomyelitis (EAE) in Mice by the Water-Soluble Carbon Monoxide-Releasing Molecule (CORM)-A1.” Clinical and Experimental Immunology 163 (3): 368–74. doi:10.1111/j.1365-2249.2010.04303.x.